| __timestamp | Mesoblast Limited | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 54170000 | 72471000 |
| Thursday, January 1, 2015 | 65378000 | 89204000 |
| Friday, January 1, 2016 | 52263000 | 106010000 |
| Sunday, January 1, 2017 | 35072000 | 137905000 |
| Monday, January 1, 2018 | 27415000 | 159888000 |
| Tuesday, January 1, 2019 | 36983000 | 158425000 |
| Wednesday, January 1, 2020 | 50918000 | 200677000 |
| Friday, January 1, 2021 | 63586000 | 304759000 |
| Saturday, January 1, 2022 | 57967000 | 377221000 |
| Sunday, January 1, 2023 | 53107000 | 336361000 |
| Monday, January 1, 2024 | 23626000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Supernus Pharmaceuticals, Inc. and Mesoblast Limited from 2014 to 2023. Supernus Pharmaceuticals has consistently outpaced Mesoblast in SG&A spending, with a peak in 2022 where their expenses were nearly 6.5 times higher than Mesoblast's. This trend highlights Supernus's aggressive investment in administrative and sales functions, possibly reflecting a strategy focused on rapid growth and market penetration. In contrast, Mesoblast's expenses have shown more fluctuation, with a notable dip in 2018, suggesting a more conservative or fluctuating approach. The data for 2024 is incomplete, indicating a need for further analysis to understand future trends. This comparison offers a fascinating glimpse into how two companies navigate the financial demands of the pharmaceutical industry.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Novartis AG vs Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Supernus Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Opthea Limited and Mesoblast Limited
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.